Clinical and Cardiac Safety of Long-term Levofloxacin in Children Treated for Multidrug-resistant Tuberculosis

Safety concerns persist for long-term pediatric fluoroquinolone use. Seventy children (median age, 2.1 years) treated with levofloxacin 10–20 mg/kg once daily for multidrug-resistant tuberculosis (median observation time, 11.8 months) had few musculoskeletal events, no levofloxacin-attributed seriou...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Clin Infect Dis
Main Authors: Garcia-Prats, Anthony J, Draper, Heather R, Finlayson, Heather, Winckler, Jana, Burger, André, Fourie, Barend, Thee, Stephanie, Hesseling, Anneke C, Schaaf, H Simon
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2018
Teme:
Brief Reports
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6233673/
https://ncbi.nlm.nih.gov/pubmed/29788331
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciy416
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki